Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modifiers of CFTR-directed therapy

Modifiers of CFTR-directed therapy

US Patent 11510907 · Granted Nov 29, 2022

Estimated economic value: $9,314,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multipart reagents having increased avidity for polymerase binding2025
Loading nucleic acids onto substrates2025
APJ antibody, fusion protein thereof with Elabela, and pharmaceutical compositio2025
Methods and compositions for isolating asymmetric nucleic acid complexes2024
Engineered ketoreductase polypeptides and uses thereof2024
Compositions and methods for subcutaneous administration of cancer immunotherapy2024
Loading nucleic acids onto substrates2023
Compositions and methods comprising conductive metal organic frameworks and uses2023
Methods and compositions for loading of polymerase complexes2023
Engineered decarboxylase polypeptides and their application in preparing beta-al2022
Methods and compositions for delivery of molecules and complexes to reaction sit2022
Compositions and methods for subcutaneous administration of cancer immunotherapy2022